BioMarin Pharmaceutical(BMRN) - 2025 Q2 - Quarterly Results

Exhibit 99.1 Investors: Media: Traci McCarty Marni Kottle BioMarin Pharmaceutical Inc. BioMarin Pharmaceutical Inc. (415) 455-7558 (650) 374-2803 BioMarin Reports Strong Second Quarter 2025 Results and Raises Full-year Guidance for Total Revenues, Non- GAAP Operating Margin, and Non-GAAP Diluted EPS 1 Second Quarter 2025 Total Revenues of $825 million (+16% Y/Y and +17% at Constant Currency Y/Y) Second Quarter 2025 GAAP Diluted Earnings Per Share (EPS) of $1.23 (+124% Y/Y) Second Quarter 2025 Non-GAAP Dilut ...